Neurology Congress
Scientific Program
Wednesday, May 29
Opening CeremonyThe President of Iceland, Ólafur Ragnar Grímsson
Ásta Möller, member of parliament, and professor Elías Ólafsson
13:30-14:30 Hall 1
NMSC Lecture
Chair Benedikz JEG
Fredrikson S
13:30 Multiple sclerosis and its treatment: Lessons from history, L 01
literature, and science
McDonald I
14:30-15:00 Coffee
15:00-17:00 Hall 1
Multiple sclerosis I
Chair Benedikz JEG
Fredrikson S
15:00 The prognosis after an optic neuritis L 02
Fredriksen J
15:25 Prognostic possibilities in MS L 03
Fredrikson S
15:50 Cognitive aspects in MS L 04
Hämäläine P
16:15 Cortical pathology in MS L 05
Bø L
16:40 Panel discussion
15:00-17:00 Hall 4
Nursing Session I
Chair Thoroddsen Á
15:00 Scandinavian cooperation between neurologic nurses L 06
Jämsä T
15:30 Quality of life in Parkinson's disease L 07
Hagell P
16:15 Quality of MS-care in Sweden L 08
Myr Å
Thursday, May 30
08:00-08:45 Landspítali University Hospital HringbrautBoard meeting of the Nordic Neurological Association
08:30-11:30 Hall 2
Multiple sclerosis II
Chair: Benedikz JEG
Fredrikson S
08:30 The Danish interferon-beta experience L 09
Sørensen PS
09:00 Genetics of MS in Iceland L 10
Gulcher J
09:30-10:00 Coffee
10:00 Follow-up on MS patients treated with interferon beta and the L 11
importance of neutralising antibodies
Myh KM
10:30 MS in Iceland in the last century with particular emphasis on L 12
the natural history
Benedikz JEG
11:00 Panel discussion
11:30-12:30 Lunch at Radisson SAS Saga Hotel-Súlnasalur
08:30-11:30 Hall 4
Nursing Session-Stroke I
Chair Guðlaug Rakel Guðjónsdóttir, Iceland
8:30 Major nursing issues in the rehabilitation of stroke patients L 13
Kirkevold M
09:30-10:00 Coffee
10:00 Surviving to thriving. My journey as a stroke survivor L 14
Johnson J
10:45 Evidence based nursing: Setting out to measure the effects of L 15
NDT-nursing in stroke patients
Hafsteinsdóttir Þ
11:30-12:30
Radisson SAS Saga Hotel-Skáli
Lunch meeting: Nordic co-operation in Neurological Nursing/
Nordic Committee
11:30-12:30 Lunch at Radisson SAS Saga Hotel - Súlnasalur
12:30-14:30 Hall 2
Symposium on headache - Supported by GSK
Chair Sveinbjörnsdóttir S
12:30 Health care utilization and medication overuse in migraine L 16
Zwart JA
13:10 Mechanisms of migraine L 17
Olesen J
13:50 Genetics of migraine 18
Kallela M
14:20 Panel discussion
14:30-15:00 Coffee
15:00-17:00 Hall 2
Botulinum toxin treatment
Chairs Jakobsson F
Hjaltason H
15:00 Botulinum toxin treatment from the clinician's L 19
point of view
Jakobsson F
15:40 Botulinum toxin and hyperhidrosis L 20
Naver H
15:00-17:00 Hall 3
Epilepsy
Chair Ólafsson E
15:00 Epidemiology of epilepsy in Iceland L 22
Ólafsson E
15:50 Risk factors for epilepsy L 23
Hauser A
16:40 Panel discussion
15:00-17:00 Hall 4
Nursing Session-Stroke II
Chair Sveinsdóttir H
15:00 Living with eating difficulties after stroke. L 24
Nursing assessment and interventions
Jacobsson C
15:45 To love and be loved. Sexuality, stroke, and quality of life L 25
Johnson J
15:00-17:00 Hall 5
Doctors Platform Session
Chair Sveinbjörnsdóttir S
Bjarnadóttir Ó
15:00 Topiramate treatment of epilepsy in five mentally 26
retarded patients with unilateral mesial
tomporal sclerosis
Arvio M, Sillanpää M
15:10 Cholinergic system modulates auditory processing 27
in elderly subjects:
A combined MEG/EEG-study
Pekkonen E, Jääskeläinen IP, Kaakkola S, Ahveninen J
15:20 The variability of epidermal nerve fiber densities 28
in healthy individuals
Mellgren SI, Göransson J, Omdal R, Skjesol A, Lindal S
15:30 Olfactory function in neurodegenerative disease 30
Hawkes C
15:40 Epilepsy and driving licence 31
Brodtkorb E, Bråthen G, Helde G
15.50 Could multiple sclerosis be a sexually transmitted illness? 32
Hawkes C
16:00 A genome wide linkage disequilibrium screen in 33
Scandinavian multiple sclerosis patients shows
association to chromosome regions at 1q (D1S1601)
and 11q (D11S1986)
Harbo HF, Datta P, Spurkland A, Ryder LP, Sawcer S,
Celius EG, Modin H, Åkesson E, Sandberg-Wollheim M,
Myhr K-M, Andersen O, Hillert J, Sørensen PS,
Svejgaard A, Compston A, Vardal F, Oturai A
16:10 Is stroke in the young primarily of non-embolic origin? 34
The Copenhagen stroke study
Jørgensen HS, Mosegaard D, Olsen TS
16:20 Cerebral embolization is reduced by carrying out 35
coronary artery bypass surgery "at a beating heart"
Lund C, Lundblad R, Sundet K, Tennøe B, Fosse E,
Brucher R, Russell D
16:30 Spondylotic cervical myelopathy: Conservative vs 36
surgical results in a three-year follow-up study
Kadanka Z, Mares M, Bednaník J, Smrnka V, Krbec M,
Stejskal L, Chaloupka R, Surelová D, Novotny O,
Urbánek I, Dusek L
16:40 Does aerobic training improve endurance in mild MS? 37
Bjarnadóttir ÓH, Konráðsdóttir ÁD, Reynisdóttir K,
Ólafsson E
14:30-15:00 Doctors Poster Session
Hyperhomocysteinemia. A risk factor of stroke and P 01
recurrent stroke
Brander T, Christensen H, Gideon R, Truelsen T,
Boysen G, Thomas
Correlation between early TNF-a levels and ischaemic P 02
stroke severity
Losy J, Zaremba J
Entacapone is of benefit in patients with early P 03
Parkinson's disease without motor fluctuations
Brooks D, Gordin A, Poewe W, Deuschl G,
Leinonen M, Kultalaiiti E-R, Reinikainen K
Changes in heart rate variability after stroke P 04
Kristjánsson B, Hjaltason H, Stefánsson SB
Microangiopathic dementia: A case report from P 05
Singapore
Auchus AP, Chen CPLH, Wilder-Smith E, Yu GXE,
Wong MC
Stroke is different in men and in women. P 06
The Copenhagen stroke study
Jørgensen HS, Mosegaard D, Houth JG
Quality of life after stroke in Estonia P 07
Körv J, Lembra E, Roose M, Kaasik A-E
Hemiballism in a patient with intracerebral hematoma P 08
Haldre S, Körv J, Roose M
Intrathecal apolipoprotein E production is reduced in multiple sclerosis P 09
Kolleger H, Schwarz C, Bachner M, Schiefermeier M
The ICAM1 K469E dimorphism is not associated with multiple sclerosis P 10
in Sweden
Masterman T, Zhang Z, Hellgren D, Anvret M, Hillert J
Chronic reflex sympathetic dystrophy with dystonia (complex regional P 11
pain syndrome) developing months after cervical spinal cord injury
Guðmundsdóttir Þ, Daníelsdóttir G, Guðmundsdóttir V, Sveinbjörnsdóttir S
Proctalgia and Parkinson's disease P 12
Örvar KB, Sveinbjörnsdóttir S
Central extrapontine myelinolysis due to polydipsia causing basal ganglia P 13
dysfunction with Parkinsonism. A case report
Sveinbjörnsdóttir S, Daníelsdóttir G, Benediktsdóttir K
Long-term efficacy and safety of entacapone as an adjunct tolevodopa P 14
in patients with Parkinson's disease and motor fluctuations
Larsen JP, Siden Å, Worm-Petersen J, Gordin A, Reinikainen K,
Kultalahti E-R
Entacapone as an adjunct to controlled-release levodopa preparations P 15
Gordin A, Poewe W, Deuschl G, Kultalahti E-R, Haapaniemi H, Leinonen M
Reinikainen K
Friday, May 31
08:30-11:30 Hall 2Cerebrovascular disorders
Chairs Sigurðsson AP
Chimowicz M
08:30 Changes in blood pressure, temperature and blood glucose within L 38
the first hours after stroke onset
Boyesen G
09:00 Stroke reduction: Impact of HMG-CoA reductase inhibitor therapy L 39
Þorgeirsson G
09:30-10:00 Coffee
10:00 Optimal therapy for intracranial arterial stenosis: Antiplatelet agents, L 40
anticoagulation or angioplasty?
Chimowicz M
10:30 Vascular testing in patients with stroke and TIA L 41
Feldmann E
11:00 Panel discussion
11:30-12:30 Radisson SAS Saga Hotel-Skáli
General assembly of the Nordic Neurological Association lunch meeting
11:30-12:30 Lunch at Radisson SAS Saga Hotel-Súlnasalur
08:15-09:30 Hall 4
Nursing Session II
Chair Ingólfsdóttir Þ
08:15 Supporting people with chronic diseases to live with their disease 42
Jónsdóttir H
09:00 A study on bowel and bladder management of spinal cord injured 43
individual in Iceland
Kjartansdóttir M
09:30-10:00 Coffee
10:00-11:30 Hall 4
Nursing Platform Session I
Chair Jónsdóttir H
10:00 The role of the nurse specialist in a memory clinic: Outreach home 44
visits to referred patients
Jakobsen O, Hasselbalcj S, Hejl AM, Waldemar G
10:20 Voice therapy for patients with with Parkinson's disease 45
Arnardóttir E
10:40 Developing multimedia and e-learning for teaching and learning 46
the care of people with brain injury
Iggulden H
11:00 Estimation of Glasgow verbal score from the Glasgow eye and motor 47
scores in head trauma patients
Yousefi H
11:30-12:30 Lunch at Radisson SAS Saga Hotel-Súlnasalur
12:00-14:00 Hall 2
Symposium on pain-Sponsored by Pfizer
Chair Bentsen L
12:00 Gabapentin, mechanism of action, do we know anything new? L 48
Field M
12:35 New evidence for the role of gabapentin in the treatment of chronic pain L 49
Rice A
13:10 Possible role of gabapentin in the treatment of primary headaches L 50
Bendtsen L
13:45 Panel discussion
12:30-14:00 Hall 3
Update on Movement Dis./Hereditary Myopathies
Chair Jakobsson F
12:30 Parkinson's disease L 51
Larsen JP
13:10 Hereditary neuromuscular disorders L 52
Edström L
12:30-14:00 Hall 4
Update on dementias
Chair Ævarsson ÓÞ
12:30 Today's medical treatment of Alzheimer's disease and future perspectives L 53
Snædal J
13:10 Sporadic vascular dementia subtypes - an update L 54
Wallin A
13:50 Panel discussion
14:00-14:30 Coffee
14:00-17:00 Hall 2
Genetics
Chair Ólafsson E
14:30 Genealogic approach to neurological diseases L 55
Stefánsson K
15:20 Epidemiology and genetics of Parkinson's disease in Iceland L 56
Sveinbjörnsdóttir S
16:00 Localization of a susceptibility gene for common forms of stroke L 58
Grétarsdóttir S
15:00-17:00 Hall 3
Neurological monitoring in the intensive care unit (ICU)
Sponsored by Nervus
Chair Rosén I
15:00 Electrophysiological monitoring L 59
Rosen I
15:50 Bedside monitoring of cerebral energy metabolism L 60
Ståhl N
16:40 Panel discussion
15:00-17:00 Hall 4
Nursing Platform Session II
Chair Þórarinsdóttir E
15:00 Identifying nursing sensitive patient outcomes (NOC) in neuro-rehabilitation 61
at Landspítali - University hospital in Iceland
Guðmundsdóttir E, Delaney C, Thoroddsen Á
15:20 Nurses role in the treatment of patients with hyperhidrosis 62
Wilhelmsson I-L, Eriksson S
15:40 Frequency of pressure ulcer on persons with spinal cord injury in Iceland 63
Kjartansdóttir M
16:00 Social situation of people who have been diagnosed with multiple sclerosis 64
Sigurðardóttir M
14:00-14:30 Doctors and Nurses Poster Session
Doctors Posters
Electroretinographic and histologic assessment of retinal function in P 16
microphthalmia mutant mice
Eysteinsson T, Steingrímsson E, Møller A
Quantification of myosin is a valuable tool P 17
Ansved T, Ahlbeck C, Eriksson LI, Fri Y
Categorical speech perceptions and experiments with ERP: P 18
Relationship between voice onset time and N100 latency
Levy SRA, Stefánsson SB
Prevalence of obstructive sleep apnea syndrome in patients with P 19
difficult headache
Bekkelund SI, Jensen R, Olsborg C, Torbergsen T, Salvesen R
Do carpal canal stenosis predict outcome after surgical treatment P 20
for carpal tunnel syndrome?
Bekkelund SI, Pierre-Jerome C
Diagnostic disagreement in patients referred to a neurological P 21
outpatient clinic
Albretsen C, Bekkelund SI
Prevalence of head trauma in patients with difficult headache P 22
Bekkelund SI, Salvesen R
Multidisciplinary group rehabilitation for patients with Parkinson's disease P 23
Bjarnadóttir Ó, Arnardóttir E, Benediktsdóttir S, Sigurðardóttir M,
Gunnbjörnsdóttir H
The epidemiology of headache and irritable bowel syndrome in P 24
Icelandic adults - is there an association?
Ólafsdóttir LB, Sveinbjörnsdóttir S, Jakobsson F
The epidemiology of migraine in Icelandic adults P 25
Ólafsdóttir LB, Sveinbjörnsdóttir S, Jakobsson F
Maternal obstetric neuropathies in lower extremities: Frequency, P 26
localization, etiology, and prognosis
Hjaltason H, Vigfússon G, Hauksdóttir S, Steingrímsdóttir T, Ólafsson E
Nurses Posters
Documentation and quality assurance of nursing for patients with P 27
multiple sclerosis (MS) in interferon-beta treatment (IFN)
Bangsgaard L, Eskildsen M, Hansen A, Krogh H
Women's experience of multiple sclerosis P 29
Jónsdóttir H, Sigurðardóttir GM, Hafsteinsdóttir JE, Björnsdóttir ÓE
Quality assessment of nursing documentation P 30
Hvid K, Fatum H
Developing patient education of patients with Parkinson's disease in the P 31
Clinic of Neurology, Oulu University Hospital
Jämsä T, Heikkinen T, Hiltunen A, Järvimäki L, Hentinen M, Toljamo M
Implementation of new documentation procedures for the nursing in the P 32
Stroke Clinic of Frederiksberg Hospital
Hvid K, Fatum H
Quality of life before and after stroke. The Copenhagen stroke study P 33
Mosegaard D, Houth JG, Jørgensen HS
Documentation of tacit knowledge. Improving MS nursing P 34
Jota PA, Haugstad R, Kornerud U, Wehus R, Klingsheim B, Nortvedt MW
Evidence-based nursing to stroke patients P 35
Zielke S, Christensen D, Muus I
Does rehabilitation improve quality of life in individuals with P 36
Parkinson's disease? Prospective pilot study
Gunnbjörnsdóttir H, Bjarnadóttir ÓH
Benefits of rehabilitation after stroke P 37
Sigurðardóttir KR, Bjarnadóttir ÓH
The need for nursing care rehabilitation in patients with acute stroke. P 38
The Copenhagen stroke study
Mosegaard D, Jørgensen HS
Saturday, June 1
08:30-10:20 Hall 1Lectures from Iceland
08:30 Results of 40 years surveillance for Creuzfeldt-Jakob disease in Iceland L 65
Georgsson G
09:10 Hereditary cystatin C amyloid angiopathy in Iceland L 66
Blöndal H
09:50-10:20 Coffee
10:20-12:20 Hall 1
The future of neurology
10:20 Neurological nursing in the Nordic countries 67
Kirkevold M
10:40 Neurology in the Nordic countries 68
Sigurðsson AP
11:00 The future of neurology 69
Hachinski V
12:00 Panel discussion
Representative from each of the Nordic countries